Diabetes
Explore diabetes
Explore obesity
Explore growth-related disorders
Explore rare bleeding disorders
Explore rare renal disorders
Explore hormone replacement therapy
Medical Information | Non-US Health Care Professionals
Account Settings
Sign Out
Sign In | Create Account
Diabetes
Time in Range (TIR)
Time in Range (TIR)
  • Overview
    • What is Time in Range (TIR)?
    • Why TIR matters
    • Clinical guidance and targets
    • How to use TIR in clinical practice
    • Understanding the AGP
    • Getting started with TIR
    • Using TIR to create action
  • Continuous glucose monitoring
  • Expert insights
  • Patient stories
AGP logo

UNDERSTANDING THE AMBULATORY GLUCOSE PROFILE (AGP) REPORT

The AGP report shows data measured by continuous glucose monitoring (CGM) in a standardized visual format, providing a comprehensive overview of the glucose profile for a person with diabetes.1-4 This can help give people with diabetes and their healthcare professionals a better understanding of glucose levels and acts as a tool to support shared decision‑making.1-4

TIR HCP Educational Content: Time in Range KOL Video of Dr. Bergenstal
(10:39)

Dr Richard Bergenstal, International Diabetes Center, Minneapolis, explains how to use the AGP to get a quick overview of a person’s glycemic variability and pinpoint areas for improvement.

Healthcare professional has received a fee from Novo Nordisk Inc. for his participation.

The one-page AGP report is based on glucose levels measured over the course of each day and night.1,4 The report displayed combines the daily data to show glucose levels over several days or weeks displayed in the context of a typical 24-hour day. Fourteen days of CGM data are generally sufficient to generate a reliable AGP report.1 Where there is a large degree of variability, a longer period of measurement may be useful.

The standardized report has been welcomed by the diabetes community2 and is recommended by the American Diabetes Association (ADA) in the 2023 Standards of Medical Care in Diabetes.4


Example one-page AGP report

Example one-page AGP Report
Example one-page AGP Report mobile version

The AGP report displays core CGM metrics and targets, as well as glucose fluctuations and daily glucose profiles.2,4 Time in Range (TIR), Time Above Range (TAR; the percentage of time spent above 180 mg/dL), and Time Below Range (TBR; the percentage of time spent below 70 mg/dL) are presented as a stacked, color-coded bar chart.

  • TIR is represented in green. According to clinical guidance, most people with diabetes should spend at least 70% of the day (around 17 hours) in the target glycemic range of 70 to 180 mg/dL2
  • TBR is represented in red (low) and dark red (very low). Most people with diabetes should spend less than 4% of their day (1 hour) below range2
    • <1% of time (15 minutes) should be spent in the "very low" TBR of <54 mg/dL.2,4 This also applies to pregnant women with type 1 diabetes
  • TAR is represented in yellow (high) and orange (very high). Most people with diabetes should spend less than 25% of their day (6 hours) above range2
    • <5% of time (~1 hour, 12 minutes) should be spent in the “very high” TAR of >250 mg/dL2,4

  1. Kröger J, Reichel A, Siegmund T, et al. Clinical Recommendations for the Use of the Ambulatory Glucose Profile in Diabetes Care. J Diabetes Sci Technol. 2020;14(3):586-594.
  2. Battelino T, Danne T, Bergenstal RM, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019;42(8):1593-1603.
  3. Carlson AL, Mullen DM, Bergenstal RM. Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes. Diabetes Technol Ther. 2017;19(S2):S4-S11.
  4. American Diabetes Association. Standards of Care in Diabetes—2023. Diabetes Care. 2023;46(suppl 1):S1-S291.

CLINICAL USE

healthcare professional icon in blue

How to use TIR in clinical practice

AGP logo in blue

Understanding the AGP

stethoscope icon in blue

Getting started with TIR

calendar icon in blue

Using TIR to create action

Diabetes
Explore diabetes
Explore obesity
Explore growth-related disorders
Explore rare bleeding disorders
Explore rare renal disorders
Explore hormone replacement therapy

novoMEDLINK™ is a trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.

Terms of Use | Privacy Notice | Consumer Health Privacy Notice | Cookie Notice | Privacy Request | Contact Us |
novonordisk-us.com    
© 2023 Novo Nordisk All rights reserved. US21HCP00098 November 2023

Quick links

Request medication samples

Diabetes treatment guidelines

Patient savings card offer

Patient support program